Bassler Bonnie L
Insider CIK 1683607 · CDTX Director · KLDO Director · RPRX Director · REGN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RPRX Royalty Pharma plc | A Award | 2026-09-30 | 2026-09-30 | 642 | $58.41 | $37.5K | 79,823 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2026-09-30 | 2026-09-30 | 642 | $58.41 | $37.5K | 79,823 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2026-06-30 | 2026-06-30 | 689 | $54.40 | $37.5K | 79,181 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2026-06-05 | 2026-06-08 | 4,545 | — | $0 | 78,492 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2026-03-31 | 2026-03-31 | 815 | $45.98 | $37.5K | 73,947 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-07 | 1,400 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-07 | 2,125 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-07 | 2,125 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-07 | 16,000 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-07 | 11,100 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-07 | 875 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-07 | 1,750 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2026-01-07 | 2026-01-08 | 1,500 | — | $0 | 2,861 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer | 2026-01-07 | 2026-01-07 | 15 | $221.50 | $3.3K | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2026-01-07 | 2026-01-08 | 1,500 | $374.12 | $561.2K | 3,203 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2026-01-07 | 2026-01-08 | 1,500 | $800.00 | $1.20M | 1,703 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2026-01-02 | 2026-01-06 | 1,962 | — | $0 | 1,962 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2026-01-02 | 2026-01-06 | 155 | — | $0 | 1,703 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2025-12-31 | 2026-01-02 | 967 | $38.74 | $37.5K | 73,132 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2025-11-20 | 2025-11-24 | 760 | — | $0 | 756 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2025-11-20 | 2025-11-24 | 760 | $371.40 | $282.3K | 2,308 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2025-11-20 | 2025-11-24 | 760 | $750.00 | $570.0K | 1,548 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2025-09-30 | 2025-09-30 | 1,047 | $35.79 | $37.5K | 72,165 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2025-06-30 | 2025-06-30 | 1,064 | $35.24 | $37.5K | 71,118 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2025-06-18 | 2025-06-18 | 11,100 | — | $0 | 11,100 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2025-05-13 | 2025-05-14 | 7,614 | — | $0 | 70,054 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2025-03-31 | 2025-04-01 | 1,141 | $32.87 | $37.5K | 62,440 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2025-01-02 | 2025-01-06 | 1,958 | — | $0 | 1,958 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2025-01-02 | 2025-01-06 | 166 | — | $0 | 1,548 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2024-12-31 | 2025-01-02 | 1,503 | $24.94 | $37.5K | 61,299 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2024-12-17 | 2024-12-19 | 16,000 | — | $0 | 16,000 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2024-09-30 | 2024-09-30 | 1,342 | $27.92 | $37.5K | 59,796 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2024-08-15 | 2024-08-19 | 756 | — | $0 | 1,516 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2024-08-15 | 2024-08-19 | 756 | $371.40 | $280.8K | 2,138 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-08-15 | 2024-08-19 | 756 | $1170.00 | $884.5K | 1,382 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2024-08-02 | 2024-08-05 | 756 | — | $0 | 2,272 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-08-02 | 2024-08-05 | 756 | $1115.00 | $842.9K | 1,382 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2024-08-02 | 2024-08-05 | 756 | $371.40 | $280.8K | 2,138 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2024-07-18 | 2024-07-19 | 2,125 | — | $0 | 2,125 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2024-06-28 | 2024-06-28 | 1,399 | $26.80 | $37.5K | 58,454 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2024-06-24 | 2024-06-25 | 756 | — | $0 | 3,028 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-06-24 | 2024-06-25 | 756 | $1062.00 | $802.9K | 1,382 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2024-06-24 | 2024-06-25 | 756 | $371.40 | $280.8K | 2,138 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2024-06-07 | 2024-06-10 | 9,293 | — | $0 | 57,055 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2024-06-05 | 2024-06-07 | 827 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-06-05 | 2024-06-07 | 827 | $1011.00 | $836.1K | 1,382 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2024-06-05 | 2024-06-07 | 827 | $380.95 | $315.0K | 2,209 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2024-03-28 | 2024-04-02 | 1,240 | $30.23 | $37.5K | 47,762 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2024-02-26 | 2024-02-26 | 854 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-02-26 | 2024-02-26 | 854 | $979.25 | $836.3K | 1,382 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2024-02-26 | 2024-02-26 | 854 | $391.92 | $334.7K | 2,236 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2024-01-30 | 2024-01-31 | 827 | — | $0 | 827 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-01-30 | 2024-01-31 | 827 | $959.00 | $793.1K | 1,382 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2024-01-30 | 2024-01-31 | 827 | $380.95 | $315.0K | 2,209 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2024-01-03 | 2024-01-04 | 826 | — | $0 | 1,654 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2024-01-03 | 2024-01-04 | 826 | $380.95 | $314.7K | 2,208 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-01-03 | 2024-01-04 | 826 | $914.00 | $755.0K | 1,382 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2024-01-02 | 2024-01-04 | 1,607 | — | $0 | 1,607 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2024-01-02 | 2024-01-04 | 135 | — | $0 | 1,382 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2023-12-29 | 2023-12-29 | 1,353 | $27.71 | $37.5K | 46,522 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2023-12-13 | 2023-12-14 | 610 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2023-12-13 | 2023-12-14 | 610 | $870.00 | $530.7K | 1,247 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2023-12-13 | 2023-12-14 | 610 | $376.69 | $229.8K | 1,857 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2023-09-29 | 2023-10-03 | 1,384 | $27.08 | $37.5K | 45,169 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2023-08-21 | 2023-08-23 | 853 | — | $0 | 854 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2023-08-21 | 2023-08-23 | 853 | $829.00 | $707.1K | 1,247 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2023-08-21 | 2023-08-23 | 853 | $391.92 | $334.3K | 2,100 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2023-08-10 | 2023-08-11 | 853 | — | $0 | 1,707 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2023-08-10 | 2023-08-11 | 853 | $391.92 | $334.3K | 2,100 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2023-08-10 | 2023-08-11 | 853 | $789.00 | $673.0K | 1,247 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2023-06-30 | 2023-06-30 | 1,208 | $31.03 | $37.5K | 43,785 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2023-06-23 | 2023-06-26 | 7,747 | — | $0 | 42,577 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2023-06-22 | 2023-06-23 | 42,500 | — | $0 | 42,500 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2023-03-31 | 2023-03-31 | 1,049 | $35.73 | $37.5K | 34,830 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2023-03-24 | 2023-03-27 | 1,240 | — | $0 | 2,480 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2023-03-24 | 2023-03-27 | 1,240 | $818.00 | $1.01M | 1,247 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2023-03-24 | 2023-03-27 | 1,240 | $380.95 | $472.4K | 2,487 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2023-02-03 | 2023-02-07 | 1,021 | — | $0 | 3,720 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2023-02-03 | 2023-02-07 | 1,021 | $380.95 | $388.9K | 2,268 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2023-02-03 | 2023-02-07 | 1,021 | $779.00 | $795.4K | 1,247 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2023-01-03 | 2023-01-05 | 1,929 | — | $0 | 1,929 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2023-01-03 | 2023-01-05 | 165 | — | $0 | 1,247 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2022-12-30 | 2023-01-03 | 943 | $39.76 | $37.5K | 33,781 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2022-12-08 | 2022-12-12 | 218 | — | $0 | 4,741 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2022-12-08 | 2022-12-12 | 218 | $380.95 | $83.0K | 1,300 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-12-08 | 2022-12-12 | 218 | $779.00 | $169.8K | 1,082 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2022-09-30 | 2022-09-30 | 913 | $41.06 | $37.5K | 32,838 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2022-09-09 | 2022-09-12 | 609 | — | $0 | 610 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-09-09 | 2022-09-12 | 609 | $741.00 | $451.3K | 1,082 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2022-09-09 | 2022-09-12 | 609 | $376.69 | $229.4K | 1,691 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2022-09-08 | 2022-09-12 | 1,279 | — | $0 | 3,839 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2022-09-08 | 2022-09-12 | 1,279 | — | $0 | 2,560 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2022-09-08 | 2022-09-12 | 1,279 | $391.92 | $501.3K | 2,361 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2022-09-08 | 2022-09-12 | 1,279 | $391.92 | $501.3K | 2,361 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-09-08 | 2022-09-12 | 1,279 | $705.00 | $901.7K | 1,082 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-09-08 | 2022-09-12 | 1,279 | $686.99 | $878.7K | 1,082 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2022-06-30 | 2022-06-30 | 903 | $41.52 | $37.5K | 31,925 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2022-06-24 | 2022-06-24 | 6,328 | — | $0 | 31,022 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2022-06-22 | 2022-06-24 | 28,000 | — | $0 | 28,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2022-04-07 | 2022-04-11 | 1,240 | — | $0 | 4,959 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-04-07 | 2022-04-11 | 1,240 | $725.00 | $899.0K | 1,082 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2022-04-07 | 2022-04-11 | 1,240 | $380.95 | $472.4K | 2,322 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2022-03-31 | 2022-04-01 | 964 | $38.87 | $37.5K | 24,694 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2022-03-30 | 2022-04-01 | 1,240 | — | $0 | 6,199 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-03-30 | 2022-04-01 | 1,240 | $700.00 | $868.0K | 1,082 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2022-03-30 | 2022-04-01 | 1,240 | $380.95 | $472.4K | 2,322 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2022-01-03 | 2022-01-05 | 2,707 | — | $0 | 2,707 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2022-01-03 | 2022-01-05 | 191 | — | $0 | 1,082 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2021-12-31 | 2022-01-03 | 958 | $39.11 | $37.5K | 23,730 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2021-09-30 | 2021-09-30 | 992 | $37.80 | $37.5K | 22,772 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2021-08-16 | 2021-08-17 | 1,219 | — | $0 | 1,219 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-08-16 | 2021-08-17 | 1,219 | $630.00 | $768.0K | 891 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2021-08-16 | 2021-08-17 | 1,219 | $376.69 | $459.2K | 2,110 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2021-08-05 | 2021-08-06 | 2,559 | — | $0 | 5,118 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-08-05 | 2021-08-06 | 2,559 | $600.00 | $1.54M | 891 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2021-08-05 | 2021-08-06 | 2,559 | $391.92 | $1.00M | 3,450 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2021-07-01 | 2021-07-02 | 2,558 | — | $0 | 7,677 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-07-01 | 2021-07-02 | 2,558 | $575.00 | $1.47M | 891 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2021-07-01 | 2021-07-02 | 2,558 | $391.92 | $1.00M | 3,449 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | A Award deriv | 2021-06-30 | 2021-07-01 | 15,000 | — | $0 | 15,000 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2021-06-30 | 2021-06-30 | 871 | $43.04 | $37.5K | 21,780 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2021-06-25 | 2021-06-29 | 5,726 | — | $0 | 20,909 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2021-06-23 | 2021-06-24 | 17,500 | — | $0 | 17,500 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2021-03-31 | 2021-04-02 | 816 | $45.90 | $37.5K | 15,183 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2021-01-22 | 2021-01-25 | 35,000 | — | $0 | 35,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2021-01-04 | 2021-01-05 | 3,613 | — | $0 | 3,613 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2021-01-04 | 2021-01-05 | 248 | — | $0 | 891 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2020-12-31 | 2021-01-04 | 820 | $45.69 | $37.5K | 14,367 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2020-09-30 | 2020-10-02 | 910 | $41.17 | $37.5K | 13,547 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | A Award deriv | 2020-06-30 | 2020-07-01 | 15,000 | — | $0 | 15,000 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2020-06-30 | 2020-09-23 | 137 | $48.00 | $6.6K | 12,637 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2020-06-19 | 2020-06-22 | 2,559 | — | $0 | 10,235 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-06-19 | 2020-06-22 | 2,548 | $630.01 | $1.61M | 654 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2020-06-19 | 2020-06-22 | 2,559 | $391.92 | $1.00M | 3,202 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-06-19 | 2020-06-22 | 11 | $631.37 | $6.9K | 643 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2020-06-18 | 2020-09-23 | 12,500 | — | $0 | 12,500 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2020-06-05 | 2020-06-05 | 2,559 | — | $0 | 12,794 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-06-05 | 2020-06-05 | 2,559 | $600.00 | $1.54M | 643 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2020-06-05 | 2020-06-05 | 2,559 | $391.92 | $1.00M | 3,202 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2020-01-02 | 2020-01-06 | 4,361 | — | $0 | 4,361 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2020-01-02 | 2020-01-06 | 320 | — | $0 | 643 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2019-01-02 | 2019-01-04 | 3,784 | — | $0 | 3,784 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award | 2019-01-02 | 2019-01-04 | 323 | — | $0 | 323 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2018-01-02 | 2018-01-03 | 7,439 | — | $0 | 7,439 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2017-01-03 | 2017-01-04 | 2,438 | — | $0 | 2,438 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2016-09-09 | 2016-09-12 | 15,353 | — | $0 | 15,353 | SEC↗ |